<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01876290</url>
  </required_header>
  <id_info>
    <org_study_id>2012/14</org_study_id>
    <secondary_id>2012-001486-32</secondary_id>
    <nct_id>NCT01876290</nct_id>
  </id_info>
  <brief_title>Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting</brief_title>
  <acronym>Loop-NVPO</acronym>
  <official_title>Should we Associate Dexamethasone and Ondansetron to Closed-loop Anesthesia to Reduce the Incidence of Postoperative Nausea and Vomiting After Bariatric Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to test if it is indicated to associate dexamethasone and ondansetron
      in obese patients having bariatric surgery under total intra-venous closed-loop anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese patients having bariatric surgery have frequently postoperative nausea and vomiting
      (PONV). We want to test if it is indicated to associate dexamethasone and ondansetron in
      obese patients having bariatric surgery under total intra-venous closed-loop anesthesia.

      Two groups to be studied: one will receive 4 mg dexamethasone at the end of the anesthetic
      induction and 4 mg ondansetron at the end of the surgical procedure, one will receive normal
      saline.

      One hundred twenty consecutive patients meeting the inclusion and exclusion criteria and who
      give written informed consent to participate in the study will be randomly assigned to one of
      two experimental groups using a 1:1 ratio.

      Patients will be continuously monitored in the post anesthesia care unit (PACU) and the
      medical floor for a total of 24 hours post operatively. Episodes of nausea, vomiting and
      administration of rescue therapy for either nausea or vomiting will be recorded and time
      stamped. In addition, severity of nausea will be evaluated by the patient using a standard
      verbal response scale (VRS) ranging from 0-10, 0 being no nausea and 10 being severe nausea.
      Rescue therapy for PONV episodes will consist of 4 mg ondansetron followed by 0.625 mg
      droperidol if necessary.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative nausea or vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>Severe nausea (&gt; to 4 on a 0-10 visual analogue scale) or vomiting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of nausea</measure>
    <time_frame>one day after anesthesia</time_frame>
    <description>incidence of nausea with delay of occurrence and severity (0-10 visual analogue scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of vomiting</measure>
    <time_frame>one day after anesthesia</time_frame>
    <description>incidence of vomiting with delay of occurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rescue treatment</measure>
    <time_frame>one day after anesthesia</time_frame>
    <description>use of rescue treatment for PONV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain</measure>
    <time_frame>one day after anesthesia</time_frame>
    <description>postoperative pain score (0-10 visual analogue scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation</measure>
    <time_frame>one day after surgery</time_frame>
    <description>postoperative sedation (0-10 visual analogue scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Dexamethasone and Ondansetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient will receive Dexamethasone and Ondansetron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Each patient will receive placebo instead of Dexamethasone and Ondansetron</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone and Ondansetron</intervention_name>
    <description>Comparison between Dexamethasone and Ondansetron and placebo in the prevention of postoperative Nausea and Vomiting</description>
    <arm_group_label>Dexamethasone and Ondansetron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients aged 18-75 years

          -  Scheduled for bariatric surgery under total intra-venous closed-loop anesthesia

          -  Apfel score equal or greater than 2

          -  Consenting to participate in the study

        Exclusion Criteria:

          -  Pregnant, breast feeding women

          -  Allergy

          -  Contraindication to dexamethasone

          -  Contraindication to ondansetron

          -  Contraindication to propofol, remifentanil, morphine, ketoprofen

          -  Limit to the use of bispectral index
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Fischler, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Foch</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique de la Baie des Citrons</name>
      <address>
        <city>Nouméa</city>
        <zip>98800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.</citation>
    <PMID>21233500</PMID>
  </reference>
  <reference>
    <citation>Song JW, Park EY, Lee JG, Park YS, Kang BC, Shim YH. The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia. Anaesthesia. 2011 Apr;66(4):263-7. doi: 10.1111/j.1365-2044.2011.06648.x.</citation>
    <PMID>21401538</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2013</study_first_submitted>
  <study_first_submitted_qc>June 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2013</study_first_posted>
  <last_update_submitted>October 28, 2016</last_update_submitted>
  <last_update_submitted_qc>October 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesiology</keyword>
  <keyword>Complications</keyword>
  <keyword>Closed-loop</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

